Skip to main content
Premium Trial:

Request an Annual Quote

Paired Ends: Francis deSouza, Guillermo Gualino, Robert Cantrell

Premium

Illumina President Francis deSouza has taken a seat on the firm's board of directors. The company added a spot on the board, boosting its number from nine to 10 seats, to accommodate deSouza. He will stand for re-election at the firm's 2014 shareholder meeting.

DeSouza joined Illumina as president in December. He previously was president of products and services at Symantec, which was acquired by Imlogic, a firm that deSouza founded and for which he served as CEO. He also worked at Microsoft, where he developed the company's real-time collaboration offerings.


Agilent Technologies has tapped Guillermo Gualino to be its VP and treasurer.

Gualino, who has been serving as assistant treasurer, replaces Robert Cantrell, who will shift to Keysight Technologies, a new electronic measurement company to be formed by Agilent's split into two publicly traded companies. Gualino will report to Agilent CFO Didier Hirsch.

Before he joined Agilent, Gualino was assistant treasurer at Flextronics International and he worked in finance at Ernst and Young, PricewaterhouseCoopers, and the Ventana Growth Fund.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.